Patient perspectives on the impact of appearance and weight changes attributed to systemic glucocorticoid treatment of rheumatic diseases

Lax, Stephanie J; Dures, Emma; Bridgewater, Susan; Silverthorne, Christine; Lowndes, Vivien; Richards, Pam; Ferreira, Andreia; Shepherd, Michael A; Dawson, Jill; Hill, Catherine; Goodman, Susan; Mackie, Sarah L; Ndosi, Mwidimi; Pearce, Fiona A; Robson, Joanna C

doi:10.1093/rheumatology/keaf121

All Outputs (2)

OA34 The contributions of Patient and Public Involvement and Engagement groups to the conduct of a scoping review of non-pharmacological interventions for reducing fatigue in children and young people with musculoskeletal conditions (2025)
Journal Article

Background/Aims Fatigue is an important symptom for people of all ages with musculoskeletal (MSK) conditions. This includes the 234,000 children and young people (CYP) in England and Scotland currently living with conditions such as juvenile inflamma... Read More about OA34 The contributions of Patient and Public Involvement and Engagement groups to the conduct of a scoping review of non-pharmacological interventions for reducing fatigue in children and young people with musculoskeletal conditions.

Patient perspectives on the impact of appearance and weight changes attributed to systemic glucocorticoid treatment of rheumatic diseases (2025)
Journal Article

Objectives To explore patients’ perspectives on the impact of appearance changes attributed to glucocorticoid treatment. Methods We conducted a secondary inductive thematic analysis of the ‘Steroid PRO’ semi-structured interviews with patients with r... Read More about Patient perspectives on the impact of appearance and weight changes attributed to systemic glucocorticoid treatment of rheumatic diseases.